Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28193
Abstract: Patients with acute coronary syndrome (ACS) might represent a specific subgroup, in which bioresorbable scaffold implantation in percutaneous coronary intervention (PCI), might lead to better outcomes when compared to conventional treatment with metallic drug eluting… read more here.
Keywords: drug eluting; aida trial; clinical outcomes; acute coronary ... See more keywords
TCT-796 A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.2030
Abstract: Females are underrepresented in clinical trials evaluating new stent technologies. This sub-analysis sought to assess sex-specific outcomes after bioresorbable scaffold implantation. The AIDA trial was an investigator-initiated, non-inferiority, all-comers trial, in which 1,845 patients were read more here.
Keywords: trial; aida trial; sex specific; outcomes bioresorbable ... See more keywords